Results 111 to 120 of about 26,940 (220)

Transition to Adulthood Through Coaching and Empowerment in Rheumatology (TRACER): Results of a Feasibility Randomized‐Control Trial

ACR Open Rheumatology, Volume 8, Issue 8, August 2026.
Objective Health care transitions are a time of high needs for youth with chronic rheumatic conditions. Our study aimed to evaluate the feasibility of a multicenter randomized‐controlled trial implementing a virtual transition coach intervention (TCI) for youth transitioning from pediatric to adult rheumatology care.
Madison Lackie, Megan Clarke, Julie Herrington, Pamela Jarvis, Roberta Berard, Karen Beattie, Michelle Batthish   +6 more
wiley   +1 more source

Impact of Evolving Treatment Patterns on Interstitial Lung Disease Progression in Systemic Sclerosis Using the European Scleroderma Trials and Research Database

Arthritis &Rheumatology, Volume 78, Issue 8, Page 1755-1764, August 2026.
Objective The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasingly available immunosuppressive therapies (ISTs) and antifibrotic treatments. However, their real‐world use remains unclear.
Corrado Campochiaro, Marie‐Elise Truchetet, Madelon Vonk, Giacomo De Luca, Giovanna Cuomo, Lidia P. Ananieva, Eric Hachulla, Vanessa Smith, Ana Maria Gheorghiu, Radim Becvar, Patricia Carreira, Nicolas Hunzelmann, Daniel E. Furst, Vera Ortiz‐Santamaria, Francesco Del Galdo, Marco Matucci‐Cerinic, Anna‐Maria Hoffmann‐Vold, EUSTAR collaborators   +17 more
wiley   +1 more source

Interstitial Lung Disease in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A European Multicenter Study

Arthritis &Rheumatology, Volume 78, Issue 8, Page 1718-1730, August 2026.
Objective Interstitial lung disease (ILD) can occur in association with antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV‐ILD) or as an isolated entity with positive ANCA (ANCA‐ILD). However, data on the epidemiology and outcomes of these conditions remain limited.
Aglaia Chalkia, Marusa Kotnik, Timothy J. Sadler, Spyridon Katechis, Rachel Jones, Ajay Kamath, Aladdin J. Mohammad, Sara Monti, Chetan Mukhtyar, Viral Nanda, Ioannis Petrakis, Dimitrios Petras, Ashnish Sinha, Pasupathy Sivasothy, Rona Smith, Kostas Stylianou, Dimitrios Vassilopoulos, Judith Babar, David Jayne   +18 more
wiley   +1 more source

Overlap of Primary Biliary Cholangitis and Systemic Sclerosis: A Case of Reynolds Syndrome

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Reynolds Syndrome should be suspected in CREST patients with persistent cholestatic liver enzymes, since delayed diagnosis allows portal hypertension and variceal bleeding to develop. Early anti‐mitochondrial antibody screening and prompt ursodeoxycholic acid therapy improve outcomes, and these patients need multidisciplinary follow‐up for ...
Ali Gohar, Ira Abid, Syeda Eman Fatima, Abdum Muneeb Sandhu, Zain Fatima, Humayun Nasir, Fatima Arshad, Abdul Rehman Shahid Khan, Muhammad Husnain Ahmad, Masab Ali   +9 more
wiley   +1 more source

Cerebral toxoplasmosis in a patient with systemic sclerosis under thalidomide treatment: A case report

JAAD Case Reports
Betul Macit, MD, Aakash Arora, BS, AB, Anthony M. Reginato, MD, PhD, Abrar A. Qureshi, MD, MPH   +3 more
doaj   +1 more source

Determinants of Abnormal Pulmonary Vasodilatory Response With Exercise in HFpEF: Pulmonary Vascular‐Left Atrial Axis Abnormalities

Comprehensive Physiology, Volume 16, Issue 4, August 2026.
Compared to traditional cardiometabolic comorbidities, COPD and atrial fibrillation are uniquely linked to pulmonary vascular remodeling in HFpEF. The impact of these two comorbidities on pulmonary vascular‐left atrial axis is highlighted by the shared biventricular morphology among HFpEF subgroups.
Mariana Garcia‐Arango, Angela Kristo, Ahmed El Shaer, Yimin Chen, Aditya Sahai, Anas Abed, Wanxin Tu, Soham Ghosh, Babak Tehrani, Shannon Heffernan, Amir Esmaeeli, Tashfeen Javaid, Ran Tao, Naga Dharmavaram, James Runo, Alejandro Roldán‐Alzate, Adam D. Gepner, Matthew Kalscheur, Colleen M. Witzenburg, Ryan J. Tedford, Farhan Raza   +20 more
wiley   +1 more source

Mechanisms of Resistance, Insights From Case Reports, and Future Prospects in Mycobacteriophage Therapy

Journal of the Royal Society of New Zealand, Volume 56, Issue 4, August 2026.
Evolution of drug‐resistant mycobacterial infections warrants renewed efforts in identifying more efficient preventive and control strategies as well as alternative treatment options. Interest in phage therapy is regaining significant traction, especially in cases of failed conventional therapy.
Buhari Yusuf, Abdul Malik, Md Shah Alam, Lijie Li, Haftay Abraha Tadesse, Aweke Mulu Belachew, Cuiting Fang, Xirong Tian, Htin Lin Aung, Shuai Wang, Tianyu Zhang   +10 more
wiley   +1 more source

Nodular Scleroderma in a Patient With Anti–RNA Polymerase III–Antibody Positive Systemic Sclerosis: A Case Report and Literature Review

The Journal of Dermatology, Volume 53, Issue 8, Page 1213-1216, August 2026.
ABSTRACT Nodular scleroderma (NS) is a rare manifestation of systemic sclerosis (SSc) that can clinically resemble keloids, often leading to diagnostic difficulty. Herein we report a case of a 76‐year‐old woman with anti–RNA polymerase III antibody–positive SSc who developed progressive erythematous, pruritic, keloid‐like plaques 3 months after ...
Kyoko Kanno, Yuki Kobayashi, Yasuyuki Fujita   +2 more
wiley   +1 more source

Nailfold video capillaroscopy in patients with suspected systemic sclerosis: a comparison of one-finger method versus eight-finger method. [PDF]

J Scleroderma Relat Disord
Doornewaard L, Haverkort D, Kersten BE, Vonk MC.   +3 more
europepmc   +1 more source

Interleukin‐40 in Systemic Sclerosis: A Treatment‐Sensitive Marker of Immune Modulation Rather Than Disease Activity

Clinical and Translational Science, Volume 19, Issue 8, August 2026.
ABSTRACT Interleukin‐40 (IL‐40) is a recently identified cytokine primarily produced by activated B cells and implicated in immune regulation across several autoimmune diseases. Although B cell–driven immune dysregulation plays a central role in systemic sclerosis (SSc), the circulating behavior and clinical relevance of IL‐40 in this disease remain ...
İbrahim Vasi, Emin Ümit Bağrıaçık, Rıza Can Kardaş, Nihan Örüklü, Melek Yaman, Derya Yıldırım, Burcugül Kaya, Rahime Duran, İbrahim Karaduman, İbrahim Yahya Çakır, Hamit Küçük, Berna Göker, Abdulsamet Erden, Mehmet Akif Öztürk   +13 more
wiley   +1 more source